Clinical Trials Information System (CTIS)

📣Attention all clinical trial sponsors who are planning to conduct a study in the EU or EEA!

Beginning on January 31, 2023, the Clinical Trials Information System (CTIS) must be used to submit any new clinical trial application in these regions. This new process permits a single application to secure authorizations in up to 30 countries! Watch the following webinar part to learn more about the first steps in CTIS.

Click here to watch the full webinar organized by the Polish Association for Good Clinical Practice (GCPpl).

Questions?

Newsletter

Join our science community with Press Forward, our quarterly newsletter. Get the latest in dermatology clinical research. Subscribe now!

Newsletter subscription resources

*By subscribing to our newsletter, you acknowledge and agree to the terms of our privacy policy.

Case Study

"Working with Innovaderm for our alopecia areata trial has been a smooth and exceptional experience (...)” - An Inmagene Biopharmaceuticals Testimonial

Our remarkable team has received high praise from yet another satisfied customer! "Working with Innovaderm for our alopecia areata trial has been a smooth and exceptional experience, marked by their extensive expertise, proactive approach, and seamless collaboration." Duong Nguyen, Head of Clinical Operations at Inmagene Biopharmaceuticals. “Innovaderm’s profound understanding of alopecia areata and their forward-thinking […]

Blog Article

The Intricacies of Multicenter Studies in Alopecia Areata

Table of contents Alopecia Areata: The Condition The Severity of Alopecia Tool (SALT) Participation of Severe AA Patients in Clinical Trials Challenges in Limiting Studies to Severe AA Patients Implementing a Cap for Balanced Trials AA Treatment Alopecia Areata: The Condition Alopecia Areata (AA) is a medical condition characterized by hair loss that occurs […]

Blog Article

Atopy and Alopecia Areata: A Leading Pair

Table of contents Importance of Understanding Atopy as a Comorbidity in AA Relationship Between AD and AA Overview of Allergies in AA patients Significance of Eosinophils and Mast Cells Dupilumab as a Double Treatment of AA and AD Alopecia areata (AA) and atopy, which is a predisposition to develop allergic reactions, share a significant connection. […]